Skip to main content
Smart Investors Daily
Datavault AI Inc. logo

NASDAQ · DVLT

Datavault AI Inc.

Technology · Information Technology Services

$0.21

Down-$0.00 (-1.55%)

Updated Sep 10, 2026, 11:36 PM

SID Score

3.3/10

Composite research score

Smart Money

Institutional and insider signal

Market cap
413.56M
P/E ratio
-1.7
Dividend yield
0.00%
52-week range
$0.18 – $4.03
Volume
44.82M
Avg. volume
78.85M

Price performance

DVLT price history

1M range · 0 trading sessions · Daily adjusted prices

DVLT does not have enough price history for the selected period.

Data unavailable

Market data is busy. Please try again shortly.

Latest DVLT news

The latest Smart Investors Daily articles mentioning DVLT.

DVLT research

Overview

Company profile and research snapshot.

Company profile

Datavault AI Inc is a data technology and licensing company that enables clients and strategic partners to monetize their Blockchain Data and AI Web 3.0 assets via tokenization, data ownership and digital twins offering two solutions: Data Science licenses High-Performance Computing (HPC) software applications and Web 3.0 data management serving the biotech, energy, education, fintech, real estate, and healthcare industries, among others. Acoustic Science licenses spatial and multichannel HD sound transmission, including proprietary brands ADIO, WiSA and Sumerian, to customers in sports & entertainment, events & venues, restaurants, automotive, finance, and other industries.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Average target
Implied upside
Analysts
DVLT recent ratings
DateFirmRatingTarget
Aug 5, 2026Litchfield HillsBuy
Mar 30, 2026Maxim GroupBuy
Jan 5, 2026Maxim GroupBuy
Jun 12, 2025Maxim GroupBuy
Open full forecast

News briefing

Generated Sep 10, 2026, 9:21 PM

Why Is DVLT Down Today?

Datavault AI Inc. (DVLT) declined 1.55% today despite positive company developments, suggesting retail investors remain skeptical even as institutional interest builds around near-term catalysts. The stock's weakness comes as the company prepares for a significant platform launch, indicating a classic disconnect between bullish corporate news and bearish market sentiment.

    Bottom line: DVLT's today's decline appears counterintuitive given concrete platform launch timelines and partnership expansion, but reflects the market's skepticism about execution and valuation at this pre-commercial stage. Investors should monitor the September 15 launch closely as a critical make-or-break event that could decisively shift sentiment in either direction; near-term volatility should be expected.

    Yahoo · Sep 8, 2026

    Datameds, AI., and Tollo Health Partner with the NFL Alumni Association for Health Lives Here National Campaign Rollout

    Leading Healthcare IT Company and Former NFL Players Will Work Together to Provide Rural Communities Access to Telehealth and Pharmacy-based Services Through Health Lives Here Mobile AppTAMPA, FL / ACCESS Newswire / September 8, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS," or the "Company"), a healthcare company leveraging its Health IT and physical infrastructure together with its artificial intelligence platform EinsteinRx™ and smart contracts platform PharmacyChain™,and

    AI research layers

    Interpretive context generated from the platform’s current data sources.

    No results

    AI research layers have not been published yet.